Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Titrimetric Assay Development for Acidity – V 2.0

Posted on By

Analytical Method Development: Titrimetric Assay Development for Acidity – V 2.0

SOP for Titrimetric Assay Development for Acidity in the AMD Department


Department Analytical Method Development
SOP No. SOP/AMD/044/2025
Supersedes SOP/AMD/044/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the procedure for developing, optimizing, and validating titrimetric methods for the quantification of acidity in pharmaceutical APIs and formulations.

The goal is to ensure accurate, reproducible, and GMP-compliant acidity measurements aligned with pharmacopeial and regulatory requirements.

2. Scope

This SOP applies to all acidity assay method development activities performed in the Analytical Method Development (AMD) laboratory for APIs, raw materials, and dosage forms including syrups, suspensions, injectables, and tablets.

3. Responsibilities

  • Analytical Scientist: Performs method development and documents observations and results.
  • Reviewer: Verifies method performance characteristics and confirms calculations.
  • QA: Reviews final method and validation data for compliance with quality standards.
  • Head – AMD: Approves the validated method and ensures proper archiving and reporting.
See also  Analytical Method Development: Troubleshooting Methods Developed in AMD - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that titrimetric methods developed for acidity determination are accurate, validated, and available for technology transfer and regulatory submission.

5. Procedure

5.1 Selection of Titration Method

  1. Determine if acid strength is strong (e.g., HCl) or weak (e.g., acetic acid).
  2. Select appropriate titrant:
    • NaOH (0.1 N or 0.05 N) for most organic and inorganic acids
    • Use phenolphthalein or methyl orange based on pKa
  3. Reference compendial methods (USP, Ph. Eur.) where available.

5.2 Sample Preparation

  1. Weigh accurately 0.2–1.0 g of API or formulation equivalent.
  2. Dissolve in purified water (or ethanol/water mixture if needed).
  3. Use Annexure-1: Sample Preparation Record for Acidity Assay to document solution preparation.

5.3 Titration Procedure

  1. Pipette an aliquot into a clean conical flask.
  2. Add 2–3 drops of selected indicator.
  3. Titrate with standard 0.1 N NaOH from a calibrated burette until endpoint is reached (color change observed).
  4. Repeat titration to obtain concordant values (≤ 0.1 mL difference).
  5. Calculate acidity using the formula:
    Acidity (%) = (V × N × Eq. Wt × 100) / Sample Weight (mg)
    
  6. Document results in Annexure-2: Titrimetric Calculation Sheet.
See also  Analytical Method Development: Preparation and Use of Placebos in Method Development - V 2.0

5.4 Method Optimization

  1. Optimize titrant strength based on:
    • Expected acid concentration
    • Sample matrix and solubility
  2. Evaluate impact of:
    • Solvent system
    • Sample quantity
    • Indicator performance
  3. Record observations in Annexure-3: Method Development Worksheet.

5.5 Method Validation

  1. Perform validation as per ICH Q2(R1):
  2. Specificity: Ensure no interference from excipients or buffers.
  3. Accuracy: Recovery between 98–102% of theoretical acid content.
  4. Precision: %RSD ≤ 2.0% for six replicates.
  5. Linearity: Five concentration levels; r² ≥ 0.999.
  6. Robustness: Test against minor variations in titrant strength, volume, and temperature.
  7. Compile data in Annexure-4: Validation Summary Report.

6. Abbreviations

  • AMD: Analytical Method Development
  • USP: United States Pharmacopeia
  • RSD: Relative Standard Deviation
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Sample Preparation Record for Acidity Assay – Annexure-1
  2. Titrimetric Calculation Sheet – Annexure-2
  3. Method Development Worksheet – Annexure-3
  4. Validation Summary Report – Annexure-4
See also  Analytical Method Development: Change Control for Developed Methods - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <401>, <621> – Titrimetry
  • Ph. Eur. Monographs – Acid-Base Assay Techniques
  • 21 CFR Part 211 – Subpart I: Laboratory Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Preparation Record for Acidity Assay

Date Sample Name Weight Taken (mg) Solvent Prepared By
02/05/2025 API-A 500 Water Ajay Mehra

Annexure-2: Titrimetric Calculation Sheet

Trial No. Volume of Titrant (mL) Normality Sample Weight (mg) Acidity (%)
1 12.5 0.1 500 0.91

Annexure-3: Method Development Worksheet

Parameter Condition Observation Conclusion
Indicator Phenolphthalein Sharp pink endpoint Suitable

Annexure-4: Validation Summary Report

Parameter Acceptance Criteria Result Status
Precision RSD ≤ 2% 1.2% Pass
Accuracy 98–102% 99.3% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated calculation logic and validation requirements Regulatory Audit Alignment
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Use of Material Transfer Hatches – V 2.0
Next Post: API Manufacturing: SOP for IPC Sample Retention Procedure – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version